Lenka Š.
- Country
- Czechia
- Department
- Oddělení pnuemoonkologické a klinické onkologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 106 partner sites.
Specializations
Oncology Focus
This investigator specializes in the treatment of advanced non-small cell lung cancer, with particular emphasis on cases involving HER2 mutations.
- Targeted Therapy Development
- HER2-Positive NSCLC Treatment
- Advanced Lung Cancer Management
The investigator's work centers on evaluating novel therapeutic approaches for patients with ERBB2 mutations in lung cancer.
Precision Medicine
The investigator focuses on personalized treatment strategies based on specific genetic mutations, particularly in the context of human epidermal growth factor receptor 2.
- Molecular Profiling
- Biomarker Analysis
- Treatment Response Assessment
Their research encompasses the evaluation of targeted therapies against specific molecular alterations in lung cancer.
Clinical Outcomes
The investigator's research interests include studying progression-free survival in advanced lung cancer patients through comparative therapeutic approaches.
- Treatment Efficacy Assessment
- Standard of Care Comparison
- Safety Profile Evaluation
Their work involves analyzing therapeutic outcomes in advanced NSCLC through systematic clinical evaluation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.